跳至主要内容
临床试验/NL-OMON33957
NL-OMON33957已完成不适用

DCE MRI in the follow-up of prostate cancer patients after radiotherapy; a matched case control stuy (Pilot) - Matched case control study.

niversitair Medisch Centrum Utrecht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Prostate cancer and therefore treated with external beam radiotherapy or I-125 implantation in the last 10 years, with a minimum follow-up of 2 years.
  • - Written informed consent.
  • Specific inclusion criteria for the case group:
  • - Biochemical failure as defined by the Phoenix criteria (nadir PSA level + 2 ng/mL)
  • - Positive prostate biopsy results

排除标准

  • Contra-indications for 3T MR imaging following the protocol of the department of Radiology UMCU.
  • Hormonal treatment < 1 year before inclusion in this study.
  • Advanced kidney disease.;Specific exclusion for the case group:
  • Contra-indication for prostate biopsy (for example oral anticoagulants use).

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验